Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide - 2Noctourism: the new safari travel trend that's changing the wildlife we can photograph in Africa
- 3Last Christmas, 3 million viewers watched a Chiefs love story — will Bills fans fall just as hard this year?
- 4Feeling wonder every day improves our health. Here’s how to do it.
- 5Instructions to Floss Appropriately and Forestall Gum Sickness
- Artemis II astronauts make long-distance call to the space station as they head home from the moon
- Which Film Has the Incomparable Melodic Score?
- Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- Remote Headphones: Improve Your Sound Insight
- Man Charged for Stealing ‘Incredibly Precious’ 286-Year-Old Violin, Worth More Than $200,000, from a Tavern
- Jesse Jackson hospitalized, under observation for a neurodegenerative condition
- It's your last chance to subscribe to Paramount+ before they raise their prices: Here's how to lock in current pricing
- Earthquake in Indonesia kills at least 1 person and sets off small tsunami
- Find the Abilities Required for Advanced Advertising Position
